...formerly CBO at Anacor Pharmaceuticals Inc. ; and Tito Serafini as CSO, formerly VP at Renovis Inc....

...consolidation of its European facilities and the wind down of operations at its U.S. subsidiary Renovis Inc....

...He also closed the company's U.S. operation, which it got via its 2007 acquisition of Renovis Inc....

...at its U.S. subsidiary Renovis Inc. Evotec, which acquired Renovis in 2007, will continue to develop Renovis'...

...ascending-dose Phase I trial in healthy volunteers with an oral VR1 antagonist . Pfizer and Renovis Inc....

...of the restructuring, Chairman and CEO Jeffrey Kindler approached Goodman, the president and CEO of Renovis Inc....

...^ chlorpyrifos is one of the compounds." FAAH inhibitors Fabien Vincent, senior scientist at the Renovis Inc....
...told SciBX . Evotec gained an FAAH inhibitor program when it completed its acquisition of Renovis...

...after the neurology, chemistry and high throughput screening company said it completed its acquisition of Renovis...

...Evotec completed its previously announced acquisition of Renovis for about 35 million shares valued at E58.8...
...before the deal closed (see BioCentury, Sept. 24, 2007). Evotec AG (Xetra:EVT; NASDAQ:EVTC), Hamburg, Germany Renovis Inc....

...running into Phase III difficulties in late-stage testing include both a neuroprotectant, NXY-059 (Cerovive) from Renovis Inc....
...NYSE:NVS; SWX:NOVN), Basel, Switzerland Paion AG (FSE:PA8), Aachen, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Renovis Inc....